FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Merck Sharp & Dohme, Wilson Facility Vytorin Recall

Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ez…

Merck Sharp & Dohme, Wilson Facility · Wilson, NC

Risk level
Class II
Reported by FDA
Oct 14, 2015
Recall ID
D-0007-2016
Check your lot numberHow we source this data

Summary

Merck Sharp & Dohme, Wilson Facility recalled Vytorin starting Aug 14, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0007-2016 on Oct 14, 2015. Reason: Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.

Product description

Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.

Lot numbers, UPCs & expiration codes

Lot number: L013425, Exp. 11/2016

Where it was sold

KY, MS and OH.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0007-2016
Classification
Class II
Status
Terminated
Recall initiated
Aug 14, 2015
FDA report date
Oct 14, 2015
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Merck Sharp & Dohme, Wilson Facility

Original FDA data

Every field from FDA enforcement report D-0007-2016, exactly as published.

Show all FDA fields
City
Wilson
State
NC
Status
Terminated
Country
United States
Event ID
72324
Address
4633 Merck Rd W
Code information
Lot number: L013425, Exp. 11/2016
Postal code
27893-9613
Report date
Oct 14, 2015
Product type
Drugs
Recall number
D-0007-2016
Classification
Class II
Recalling firm
Merck Sharp & Dohme, Wilson Facility
Termination date
May 4, 2016
Reason for recall
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.
Distribution pattern
KY, MS and OH.
Recall initiation date
Aug 14, 2015
Initial firm notification
Letter
Center classification date
Oct 5, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0007-2016, published Oct 14, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls